Cover Image
市場調查報告書

IVD(體外診斷)應用的流式細胞技術的全球市場

The World Market for Flow Cytometry in IVD Applications

出版商 Kalorama Information 商品編碼 306994
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
IVD(體外診斷)應用的流式細胞技術的全球市場 The World Market for Flow Cytometry in IVD Applications
出版日期: 2014年06月16日 內容資訊: 英文 40 Pages
簡介

流式細胞儀是強大的參考實驗室設備,現在已經成為已開發國家的最新IVD實驗室的重要組成要素。除了用於癌症的診斷之外,也用於臨床的新應用──HIV檢查和監測。至今雖然流式細胞技術的用途受限,但一般認為今後將擴大到其他的應用領域中。

本報告提供體外診斷的流式細胞技術相關調查,提供今後的市場預測,各方面應用,各地區趨勢,參與企業的市場佔有率產品概要,以及簡介等。

第1章 摘要整理

第2章 簡介

  • 所謂流式細胞技術
  • 治療數量
  • 競爭技術
    • 免疫疾病組織化學的染色
    • 螢光原位雜合
    • 血液學系統
    • 即時CD4檢查
  • CMS支付修訂
  • 合併·收購
  • 應用:癌症
    • 淋巴瘤
    • 非何杰金氏淋巴瘤
    • 何杰金氏淋巴瘤
  • 流式細胞技術的使用
    • 肺癌
    • 前列腺癌
  • 應用:HIV
  • 應用:器官移植
  • 各企業產品
    • Becton Dickinson
    • Beckman Coulter
    • EMD Millipore
    • Miltenyi Biotec
    • Partec
    • Sony Biotechnology/ iCyt

第3章 市場分析

  • 市場規模
  • 各用途市場
  • 各地區市場
  • 各國流式細胞技術市場
  • 市場佔有率

第4章 企業簡介

  • Beckman Coulter
  • Becton, Dickinson and Company
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology (iCyt)

圖表

目錄
Product Code: KLI5271977

Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. Until recently flow cytometry has been used exclusively for these purposes. Other applications are seeing procedure growth.

This report, The World Market for Flow Cytometry in In Vitro Diagnostic Applications, is Kalorama's complete market analysis of this important diagnostics segment.

  • Market and Forecast 2013-2018 for Flow Cytometry in IVD
  • Breakout by Application (Cancer, HIV, Organ Transplant, Other)
  • Regional Breakout (US, EUR, ROW)
  • Country Markets for Flow Cytometry
  • Market Share by Company
  • Products on the Market
  • Key Company Profiles

Flow cytometry is useful in biotechnology, drug development, and clinical research. This report focuses only on IVD applications for flow. As part of its analysis, Kalorama considers growth drivers for the flow cytometry market in diagnostics, examines competitive moves by companies in the market, and reimbursment trends that will affect growth long-term. Profiled manufacturers include:

  • Beckman Coulter
  • Becton, Dickinson
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology ( iCyt )

Additional Information

Kalorama Sees Static Competition in Flow Cytometry Despite New Entrants.

For years, the flow cytometry market has been a battle between Becton Dickinson and Beckman Coulter. And despite the entry of Sysmex and Sony Technology into the market, Kalorama Information doesn't expect that to change. These two terms should fight primarily for the $1,115. The finding was made in the firm's latest market research report. The World Market for Flow Cytometry.

“The two main firms hold 90% plus of the market,” said Bruce Carlson, Publisher of Kalorama Information. “As both the major firms continue to grow by innovation and acquisition, it is not likely that a firm will challenge significant market share of the two largest players in the short term.”

The report presents Kalorama's estimation of the market share for flow cytometry. Two main competitors dominate the market for these systems. BD is the clear leader of the flow cytometry market. BD continues to update its systems and test kits to maintain complete dominance of this market. Beckman Coulter is estimated to have a 22% share of the market. Beckman has made strategic acquisitions to be sure they are on the cutting edge of cytometry.

In recent years, some new competitors entered the market. EMD Millipore, owned by Merck, and Sony technologies, operating through iCyt subsidiary, have developed reputable cytometers. Most recently, Görlitz-based biotechnology and diagnostics company Partec GmbH signed up with Sysmex Corporation based in Kobe, Japan. Partec products will now be distributed worldwide under the Sysmex umbrella. Sysmex is a leading international supplier of in vitro diagnostic products, with annual sales in excess of 1.2 billion euros. Where Partec was previously active in 140 countries, it now has access to a distribution network for 60 additional countries.. Partecs HIV/AIDS, tuberculosis and malaria diagnostic products for emerging countries could see better distribution.

CMS PAYMENT REVISIONS

In July 2013, the Centers for Medicare and Medicaid Services (CMS) announced its proposed rule with regard to payment revisions under the 2014 Physician Fee Schedule (PFS) and Clinical Laboratory Fee Schedule (CLFS). The rule states that the real cost for high complexity testing such as flow cytometry in hospital laboratories can be collected from calculations based on aggregate payments by the CMS to hospitals under bundled care. However, the estimated amounts are lower than the actual costs of this testing when done in both hospitals and independent laboratories. Kalorama estimates that the implementation of the rule will lead to further drastic cuts in laboratory reimbursements. Hospital-based flow cytometry laboratories are consequently sponsored by their parent bodies, while independent laboratories depend on the actual revenues for their survival. In addition, according to this rule, the CMS slashed clinical pathology technical codes up to 75% for common services such as flow cytometry, immunohistochemistry, and fluorescence in situ hybridization. This was because the CMS considers these prices as “misvalued codes on the physician fee schedule.”

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Size and Growth of the Market
  • Conclusions

TWO: INTRODUCTION

  • About Flow Cytometry
  • Procedure Volume
  • Competitive Technologies
  • Immunohistochemical Stains (IHC)
  • Fluorescent in situ Hybridization (FISH)
  • Hematology Systems
  • Rapid CD4 Testing
  • CMS Payment Revisions
  • Mergers and Acquisitions
  • Applications - Cancer
  • Lymphomas
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Use of Flow Cytometry
  • Liver Cancer
  • Use of Flow Cytometry
  • Prostate Cancer
  • Use of Flow Cytometry
  • Applications -HIV
  • Applications - Organ Transplantation
  • Products by Company
  • Becton Dickinson
  • Beckman Coulter
  • EMD Millipore
  • Miltenyi Biotec
  • Partec
  • Sony Biotechnology/ iCyt

THREE: MARKET ANALYSIS

  • Market Size
  • Market by Application Area
  • Market by Geographic Area
  • Flow Cytometry Market by Country
  • Market Share
  • FOUR: COMPANY PROFILES
  • Beckman Coulter
  • Becton, Dickinson and Company
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology ( iCyt )

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: World Flow Cytometry Market, 2013-2018

TWO: INTRODUCTION

  • Figure 2-1: World Flow Cytometry Procedures (Comparison to ISH testing),2012-2018
  • Figure 2-2: Cancer Incidence, Worldwide, by Cancer Type

THREE: MARKET ANALYSIS

  • Figure 3-1: World Flow Cytometry Market, 2013-2018
  • Figure 3-2: The Portion of the Flow Cytometry Market Occupied by Cancer Testing,Infectious Disease Testing, Organ Transplant, and Other, 2013-2018
  • Figure 3-3: Regional Sales of Flow Cytometry Equipment and Reagents(U.S., Europe, Rest of World)
  • Figure 3-4: Flow Cytometry Market, 2013, by Country (Germany, France, Italy,China, UK, Spain, Australia, Brazil, Canada, Belgium, Netherlands, Portugal,Mexico, Singapore)
  • Figure 3-5: Estimation of the Current Market Share for Flow Cytometry

FOUR: COMPANY PROFILES

  • Table 4-1: Beckman Coulter Flow Cytometry Segment, 2011-2013
  • Table 4-2: Becton Dickinson Flow Cytometry Segment, 2011-2013
Back to Top